Prevalence and risk of gingival enlargement in patients treated with nifedipine.
about
Clinical assessment of nifedipine-induced gingival overgrowth in a group of brazilian patients.Calcium antagonists and deep gingival pockets in the population-based SHIP study.Prevalence of gingival overgrowth induced by antihypertensive drugs: A hospital-based study.Management of Cyclosporine and Nifedipine-Induced Gingival Hyperplasia.Using Salivary Nitrite and Nitrate Levels as a Biomarker for Drug-Induced Gingival Overgrowth.Nifedipine and phenytoin induce matrix synthesis, but not proliferation, in intact human gingival connective tissue ex vivo.Gingival Enlargement Induced by Felodipine Resolves with a Conventional Periodontal Treatment and Drug ModificationApplication of evidence-based dentistry: from research to clinical periodontal practice.On the Cellular and Molecular Mechanisms of Drug-Induced Gingival Overgrowth.Gingival enlargement induced by dihydropyridine calcium channel blockers in a young child.Combination of inflammatory and amlodipine induced gingival overgrowth in a patient with cardiovascular disease.Prevalence and risk of gingival enlargement in patients treated with anticonvulsant drugs.A randomized, single-blind, parallel-group clinical study to evaluate the effect of soluble beta-1,3/1,6-glucan on experimental gingivitis in man.Nifedipine induces periostin expression in gingival fibroblasts through TGF-beta.Gingival enlargement in children treated with antiepileptics.Prevalence and risk of gingival overgrowth in patients treated with diltiazem or verapamil.Felodipine-influenced gingival enlargement in an uncontrolled type 2 diabetic patient.Clinical and pharmacological variables as a risk factor for nifedipine-induced gingival overgrowth.Effect of phenytoin on collagen accumulation by human gingival fibroblasts exposed to TNF-alpha in vitro.Reliability of two measurement indices for gingival enlargement.Prevalence of gingival overgrowth among elderly patients under amlodipine therapy at a large Indian teaching hospital.Management of periodontal disease in patients using calcium channel blockers - gingival overgrowth, prescribed medications, treatment responses and added treatment costs.Local Inflammation Alters MMP-2 and MMP-9 Gelatinase Expression Associated with the Severity of Nifedipine-Induced Gingival Overgrowth: a Rat Model Study.
P2860
Q35269928-7A84AAC4-4F14-4CDE-8D7D-521A733B778BQ35827227-463B1C92-A384-42A6-B827-DB4826BC425FQ35902982-7A404D3A-0BDC-4F11-9997-B575AD819CBCQ35905140-CB877D02-D702-4E61-9237-4B223A1947F6Q36332814-E292A17A-7F4F-4992-B48C-C318E0815E5FQ36470947-CB795AD9-3C36-4024-83B8-03EAE11FEF78Q36680844-5639589B-F0B4-420E-900A-5627EB872942Q38002939-BB2F2FCE-8ADC-4989-A2F1-CDB4EDADB723Q41467496-A385D949-854C-484E-930C-A3565BB451D1Q42869649-871853B9-4B9D-4163-854E-E1E6E4F3ACB8Q42920414-86461034-343B-4564-920F-0423D0922854Q43758702-21DCF85B-F842-447E-8700-8C1201F3E614Q43934721-D5D3ADC2-FD9A-4117-AABB-B0877DF40398Q45023090-23806D08-8FC6-4887-B3E1-E5DD2D927B8DQ45260336-5B673062-B3AD-4A7A-AF60-B34FBC186D1EQ46377355-07FB27B6-D870-43F0-82A9-DB14574321C7Q46599834-70438E56-7B65-4E0D-A7CE-07151213CC18Q46760702-F43EFBCD-9CFB-4ED8-BA7F-EBDE97C21CDBQ46942426-822E28E3-0DA7-4CAB-9EF5-9520C0D57724Q47257695-7ECB887D-40E2-4269-AAD9-C7EDFFBA5CBBQ47899482-35481B27-B133-48BB-B2F3-5276F1C5B114Q53466925-42F964AA-07D8-4B01-BE26-9D5849E08DF5Q53626041-7247F9DD-B5CB-46E7-83B2-79301757036A
P2860
Prevalence and risk of gingival enlargement in patients treated with nifedipine.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Prevalence and risk of gingival enlargement in patients treated with nifedipine.
@en
Prevalence and risk of gingival enlargement in patients treated with nifedipine.
@nl
type
label
Prevalence and risk of gingival enlargement in patients treated with nifedipine.
@en
Prevalence and risk of gingival enlargement in patients treated with nifedipine.
@nl
prefLabel
Prevalence and risk of gingival enlargement in patients treated with nifedipine.
@en
Prevalence and risk of gingival enlargement in patients treated with nifedipine.
@nl
P2093
P1476
Prevalence and risk of gingival enlargement in patients treated with nifedipine.
@en
P2093
P304
P356
10.1902/JOP.2001.72.5.605
P407
P577
2001-05-01T00:00:00Z